3.30 INR
185.37 M INR
745.73 M INR
About SHUKRA PHARMACEUTICALS LIMITED
Sector
CEO
Daksheshbhai R. Shah
Headquarters
Ahmedabad
Website
Founded
1993
ISIN
INE551C01028
FIGI
BBG000DM6JG1
Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. Its portfolio includes antibiotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic. The company was founded on March 4, 1993 and is headquartered in Ahmedabad, India.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SHUKRAPHAR is 72.69 INR — it has increased by 9.49% in the past 24 hours. Watch SHUKRA PHARMACEUTICALS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SHUKRA PHARMACEUTICALS LIMITED stocks are traded under the ticker SHUKRAPHAR.
SHUKRAPHAR stock has risen by 20.65% compared to the previous week, the month change is a 15.09% rise, over the last year SHUKRA PHARMACEUTICALS LIMITED has showed a 158.18% increase.
SHUKRAPHAR reached its all-time high on Jun 20, 2024 with the price of 129.90 INR, and its all-time low was 1.19 INR and was reached on Nov 7, 2013. View more price dynamics on SHUKRAPHAR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SHUKRAPHAR stock is 9.82% volatile and has beta coefficient of 0.79. Track SHUKRA PHARMACEUTICALS LIMITED stock price on the chart and check out the list of the most volatile stocks — is SHUKRA PHARMACEUTICALS LIMITED there?
Yes, you can track SHUKRA PHARMACEUTICALS LIMITED financials in yearly and quarterly reports right on TradingView.
SHUKRAPHAR net income for the last quarter is 5.39 M INR, while the quarter before that showed 4.85 M INR of net income which accounts for 11.04% change. Track more SHUKRA PHARMACEUTICALS LIMITED financial stats to get the full picture.
Yes, SHUKRAPHAR dividends are paid annually. The last dividend per share was 1.00 INR. As of today, Dividend Yield (TTM)% is 1.51%. Tracking SHUKRA PHARMACEUTICALS LIMITED dividends might help you take more informed decisions.
SHUKRA PHARMACEUTICALS LIMITED dividend yield was 1.22% in 2023, and payout ratio reached 23.62%. The year before the numbers were 1.07% and 1.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHUKRA PHARMACEUTICALS LIMITED EBITDA is 154.51 M INR, and current EBITDA margin is 26.09%. See more stats in SHUKRA PHARMACEUTICALS LIMITED financial statements.
Like other stocks, SHUKRAPHAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHUKRA PHARMACEUTICALS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHUKRA PHARMACEUTICALS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHUKRA PHARMACEUTICALS LIMITED stock shows the buy signal. See more of SHUKRA PHARMACEUTICALS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.